Pharmacokinetic/Pharmacodynamic Parameters of NNG-DEPO (Stimus) With Aranesp ® (Amgen) in Treatment of Anemia in CKD Patients on Dialysis
Condition: Chronic Kidney Disease Intervention: Biological: Stimus Sponsors: Nanogen Pharmaceutical Biotechnology Joint Stock Company; Vietstar Biomedical Research; Clinical Research Consultants, Inc.; Clinical Research Viet Nam Skill Training And Consultant Company Limited Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2022 Category: Research Source Type: clinical trials
A Study to Compare Efficacy and Safety of Nanogen's Darbepoetin Alfa With Aranesp ® (Amgen) in the Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis (CKD).
Conditions: Anemia; Chronic Kidney Disease Requiring Chronic Dialysis Intervention: Biological: Stimus (NNG-DEPO) Sponsors: Nanogen Pharmaceutical Biotechnology Joint Stock Company; Vietstar Biomedical Research; MEDPHASE CLINICAL RESEARCH CONSULTANT COMPANY LIMITED; CLINICAL RESEARCH VIET NAM SKILL TRAINING AND CONSULTING COMPANY LIMITED; MedProve Inc Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2022 Category: Research Source Type: clinical trials
